The Situation ____________ A Pharmaceutical company with an FDA-approved treatment for Dyskinesia in Parkinson’s patients aimed to strategically expand into therapies for off-episodes. To effectively navigate an evolving and competitive treatment landscape, the client needed continuous, detailed insights into clinical and commercial developments. The Solution ____________ Sedulo Group designed a tailored early warning monitoring program, combining meticulous analysis of press …
